Clinical Trials

NCT04647435 | COMPLETED | PHASE3

396 participants

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2023-05-13

Completion:

2024-10-04

Conditions

• Postsurgical Pain
• Third Molar Extraction

Interventions

• DRUG

No Results Yet

NCT04626362 | COMPLETED | NA

55 participants

American Cranberries to Prevent UTIs in Susceptible Women

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-02-02

Completion:

2026-08-20

Conditions

• Healthy

Interventions

• OTHER

No Results Yet

NCT04612803 | WITHDRAWN | PHASE3

0 participants

Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-02-01

Completion:

2026-08-31

Conditions

• Irritable Bowel Syndrome
• Dermatographism
• Post-prandial Diarrhea

Interventions

• DRUG

No Results Yet

NCT04609046 | ACTIVE_NOT_RECRUITING | PHASE1

47 participants

Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-05-24

Completion:

2027-04-01

Conditions

• Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT04599192 | ACTIVE_NOT_RECRUITING

500 participants

Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-04

Start Date:

2019-04-19

Completion:

2028-08-31

Conditions

• Coronary Disease
• Percutaneous Coronary Intervention
• Exercise Test
• Myocardial Perfusion Imaging
• Cardiac Catheterization

Interventions

• OTHER

No Results Yet

NCT04597359 | ACTIVE_NOT_RECRUITING | PHASE2

360 participants

To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-10-05

Completion:

2026-12-31

Conditions

• Prostate Carcinoma

Interventions

• DRUG
• OTHER

No Results Yet

NCT04589845 | ACTIVE_NOT_RECRUITING | PHASE2

920 participants

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-01-18

Completion:

2032-09-25

Conditions

• Solid Tumors

Interventions

• DRUG

No Results Yet

NCT04574518 | ACTIVE_NOT_RECRUITING | NA

223 participants

Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2022-08-12

Completion:

2026-03-31

Conditions

• Solitary Pulmonary Nodule
• Multiple Pulmonary Nodules
• Tobacco Use

Interventions

• BEHAVIORAL

No Results Yet

NCT04447911 | RECRUITING | PHASE4

113 participants

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-02-04

Completion:

2026-09-15

Conditions

• Hyponatremia
• SIADH
• Liver Failure
• Kidney Failure

Interventions

• DRUG

No Results Yet

NCT04447183 | COMPLETED | PHASE2

123 participants

rhTSH for Radioactive Iodine Remnant Ablation in Differentiated Thyroid Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-11-23

Completion:

2022-05-31

Conditions

• Differentiated Thyroid Cancer

Interventions

• DRUG
• OTHER

No Results Yet

NCT04429087 | ACTIVE_NOT_RECRUITING | PHASE1

300 participants

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-07-29

Completion:

2026-08-31

Conditions

• Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3

Interventions

• DRUG

No Results Yet

NCT04427527 | COMPLETED | NA

29772 participants

Accelerating Colorectal Cancer Screening Through Implementation Science in Appalachia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-08-19

Completion:

2025-03-31

Conditions

• Colorectal Cancer

Interventions

• BEHAVIORAL

Results Available

NCT04409236 | ACTIVE_NOT_RECRUITING | NA

427 participants

Quit2Heal Smartphone App in Helping Cancer Patients Quit Smoking

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-07-19

Completion:

2025-09-11

Conditions

• Hematopoietic and Lymphoid System Neoplasm
• Malignant Solid Neoplasm

Interventions

• BEHAVIORAL
• OTHER

Results Available

NCT04402788 | SUSPENDED | PHASE2/PHASE3

138 participants

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-01-07

Completion:

2027-04-30

Conditions

• Extensive Stage Lung Small Cell Carcinoma

Interventions

• DRUG
• PROCEDURE
• RADIATION

No Results Yet

NCT04391049 | ACTIVE_NOT_RECRUITING | PHASE1

16 participants

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-12-02

Completion:

2024-10-06

Conditions

• Advanced Esophageal Adenocarcinoma
• Advanced Gastroesophageal Junction Adenocarcinoma
• Clinical Stage II Esophageal Adenocarcinoma AJCC v8
• Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
• Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
• Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Clinical Stage III Esophageal Adenocarcinoma AJCC v8
• Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage II Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage III Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
• Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8
• Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8
• Unresectable Gastroesophageal Junction Adenocarcinoma
• Squamous Cell Carcinoma
• Squamous Cell Cancer

Interventions

• DRUG
• RADIATION
• BIOLOGICAL

Results Available

NCT04367246 | RECRUITING

300 participants

Li-Fraumeni Syndrome/TP53 Biobank

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-04

Start Date:

2019-09-24

Completion:

2029-09-24

Conditions

• Li-Fraumeni Syndrome
• Li-Fraumeni-Like Syndrome

Interventions

• OTHER

No Results Yet

NCT04340141 | ACTIVE_NOT_RECRUITING | PHASE3

358 participants

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-10-13

Completion:

2028-12-31

Conditions

• Pancreatic Adenosquamous Carcinoma
• Resectable Pancreatic Adenocarcinoma
• Stage I Pancreatic Cancer AJCC v8
• Stage II Pancreatic Cancer AJCC v8
• Stage III Pancreatic Cancer AJCC v8

Interventions

• DRUG
• PROCEDURE
• OTHER

No Results Yet

NCT04315233 | TERMINATED | PHASE1

12 participants

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-05-03

Completion:

2024-03-14

Conditions

• Metastatic Breast Cancer
• Recurrent Ovarian Carcinoma

Interventions

• DRUG

Results Available

NCT04269902 | RECRUITING | PHASE3

247 participants

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-03-02

Completion:

2028-10-01

Conditions

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Interventions

• PROCEDURE
• BIOLOGICAL
• OTHER
• DRUG

No Results Yet

NCT04267848 | RECRUITING | PHASE3

1210 participants

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-06-16

Completion:

2027-01-31

Conditions

• Lung Non-Small Cell Carcinoma
• Lung Non-Small Cell Squamous Carcinoma
• Lung Non-Squamous Non-Small Cell Carcinoma
• Stage II Lung Cancer AJCC v8
• Stage IIIA Lung Cancer AJCC v8
• Stage IIIB Lung Cancer AJCC v8

Interventions

• PROCEDURE
• DRUG
• OTHER
• BIOLOGICAL

No Results Yet

NCT04254185 | ACTIVE_NOT_RECRUITING | NA

378 participants

Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-02-18

Completion:

2027-10-31

Conditions

• Neuropathy Ulnar

Interventions

• PROCEDURE

No Results Yet

NCT04250116 | COMPLETED | PHASE4

960 participants

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-04-28

Completion:

2026-05-08

Conditions

• Atrial Fibrillation

Interventions

• DRUG

No Results Yet

NCT04243499 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

293 participants

First-in-Human Study of ICT01 in Patients With Advanced Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-03-05

Completion:

2027-10-15

Conditions

• Solid Tumor, Adult
• Hematopoietic/Lymphoid Cancer

Interventions

• BIOLOGICAL

No Results Yet

NCT04239573 | RECRUITING

770 participants

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-04

Start Date:

2020-06-16

Completion:

2034-11-11

Conditions

• Pancreatic Neoplasm

Interventions

• PROCEDURE
• OTHER

No Results Yet

NCT04230356 | RECRUITING | PHASE2

180 participants

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-01-27

Completion:

2028-03-31

Conditions

• Allogeneic Stell Cell Transplant
• Viral Infection

Interventions

• BIOLOGICAL

No Results Yet

NCT04192591 | ACTIVE_NOT_RECRUITING | NA

166 participants

A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-01-30

Completion:

2038-02-28

Conditions

• Lumbar Spinal Stenosis

Interventions

• DEVICE

No Results Yet

NCT04176172 | ACTIVE_NOT_RECRUITING | PHASE3

340 participants

Optimizing Tobacco Use Treatment for PLWHA

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-02-17

Completion:

2026-11-30

Conditions

• HIV/AIDS
• Nicotine Dependence

Interventions

• DRUG
• BEHAVIORAL

No Results Yet

NCT04123314 | RECRUITING | EARLY_PHASE1

20 participants

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2021-03-24

Completion:

2027-06-30

Conditions

• Depressive Symptoms
• Depression
• Alzheimer Disease
• Mild Cognitive Impairment

Interventions

• DRUG

No Results Yet

NCT04113382 | RECRUITING | PHASE1/PHASE2

39 participants

Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2022-06-23

Completion:

2027-12-31

Conditions

• Bowel Preparation

Interventions

• DRUG

No Results Yet

NCT04094610 | RECRUITING | PHASE1/PHASE2

75 participants

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-03-12

Completion:

2026-09-30

Conditions

• Locally Advanced Solid Tumors
• Metastatic Solid Tumors
• Lymphoma
• Primary CNS Tumors

Interventions

• DRUG

No Results Yet

NCT04016376 | COMPLETED | PHASE4

1507 participants

Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2019-07-05

Completion:

2026-02-25

Conditions

• Breast Cancer
• Breast Cancer Female

Interventions

• DRUG

Results Available

NCT04013854 | ACTIVE_NOT_RECRUITING | PHASE2

67 participants

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2020-01-01

Completion:

2025-10-29

Conditions

• Melanoma Stage III
• Melanoma

Interventions

• DRUG

No Results Yet

NCT04009499 | COMPLETED | PHASE3

1131 participants

A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2019-08-13

Completion:

2026-05-26

Conditions

• Psoriatic Arthritis

Interventions

• DRUG

No Results Yet

NCT04005690 | RECRUITING | EARLY_PHASE1

90 participants

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2019-08-01

Completion:

2027-06-01

Conditions

• Locally Advanced Pancreatic Ductal Adenocarcinoma
• Metastatic Pancreatic Ductal Adenocarcinoma
• Stage II Pancreatic Cancer AJCC v8
• Stage III Pancreatic Cancer AJCC v8
• Stage IV Pancreatic Cancer AJCC v8
• Unresectable Pancreatic Ductal Adenocarcinoma
• Borderline Resectable Pancreatic Ductal Adenocarcinoma
• Resectable Pancreatic Ductal Adenocarcinoma

Interventions

• DRUG
• BIOLOGICAL

No Results Yet

NCT03964090 | ACTIVE_NOT_RECRUITING | PHASE2

48 participants

Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2019-06-27

Completion:

2028-12-31

Conditions

• Central Nervous System Lymphoma
• Secondary Central Nervous System Lymphoma

Interventions

• DRUG

No Results Yet

NCT03942081 | RECRUITING | NA

500 participants

Diabetic Foot Ulcer Imaging- Study 2

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2017-09-05

Completion:

2026-12-31

Conditions

• Foot Ulcer
• Foot Ulcer, Diabetic

Interventions

• DEVICE

No Results Yet

NCT03911388 | RECRUITING | PHASE1

24 participants

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2019-09-12

Completion:

2026-09-01

Conditions

• Neoplasms, Brain
• Glioblastoma Multiforme
• Glioblastoma of Cerebellum
• Neoplasms
• Astrocytoma
• Astrocytoma, Cerebellar
• Neuroectodermal Tumors
• Neuroectodermal Tumors, Primitive
• Cerebellar PNET, Childhood
• Cerebellar Neoplasms
• Cerebellar Neoplasms, Primary
• Cerebellar Neoplasm, Malignant
• Cerebellar Neoplasm Malignant Primary
• Neoplasm Metastases
• Neoplasm Malignant
• Neoplasms, Neuroepithelial
• Neoplasms, Germ Cell and Embryonal
• Neoplasms by Histologic Type
• Neoplasms, Glandular and Epithelial
• Neoplasms, Nerve Tissue
• Central Nervous System Neoplasms, Primary
• Central Nervous System Neoplasms, Malignant
• Nervous System Neoplasms
• Neoplasms by Site
• Brain Diseases
• Central Nervous System Diseases
• Nervous System Diseases
• Medulloblastoma Recurrent
• HSV
• Virus
• Pediatric Brain Tumor
• Nervous System Cancer
• Primitive Neuroectodermal Tumor (PNET) of Cerebellum

Interventions

• BIOLOGICAL

No Results Yet

NCT03895645 | ENROLLING_BY_INVITATION

1000 participants

Connors Protocol for the Management and Use of Stored Human Specimens (Stored Human Specimens)

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-04

Start Date:

2026-09-09

Completion:

2029-12-31

Conditions

• Healthy Volunteer Samples

No Results Yet

NCT03866382 | RECRUITING | PHASE2

314 participants

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2019-05-13

Completion:

2027-02-28

Conditions

• Bladder Adenocarcinoma
• Bladder Clear Cell Adenocarcinoma
• Bladder Mixed Adenocarcinoma
• Bladder Neuroendocrine Carcinoma
• Bladder Small Cell Neuroendocrine Carcinoma
• Bladder Squamous Cell Carcinoma
• Chromophobe Renal Cell Carcinoma
• Collecting Duct Carcinoma
• Invasive Bladder Giant Cell Urothelial Carcinoma
• Invasive Bladder Lymphoepithelioma-Like Carcinoma
• Invasive Bladder Nested Urothelial Carcinoma
• Invasive Bladder Plasmacytoid Urothelial Carcinoma
• Invasive Bladder Sarcomatoid Urothelial Carcinoma
• Invasive Bladder Urothelial Carcinoma
• Kidney Medullary Carcinoma
• Large Cell Neuroendocrine Carcinoma
• Malignant Testicular Leydig Cell Tumor
• Malignant Testicular Sertoli Cell Tumor
• Metastatic Bladder Carcinoma
• Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma
• Metastatic Bladder Giant Cell Urothelial Carcinoma
• Metastatic Bladder Large Cell Neuroendocrine Carcinoma
• Metastatic Bladder Lipid-Rich Urothelial Carcinoma
• Metastatic Bladder Micropapillary Urothelial Carcinoma
• Metastatic Bladder Plasmacytoid Urothelial Carcinoma
• Metastatic Bladder Sarcomatoid Urothelial Carcinoma
• Metastatic Bladder Small Cell Neuroendocrine Carcinoma
• Metastatic Bladder Squamous Cell Carcinoma
• Metastatic Chromophobe Renal Cell Carcinoma
• Metastatic Kidney Medullary Carcinoma
• Metastatic Malignant Genitourinary System Neoplasm
• Metastatic Papillary Renal Cell Carcinoma
• Metastatic Penile Carcinoma
• Metastatic Prostate Small Cell Neuroendocrine Carcinoma
• Metastatic Sarcomatoid Renal Cell Carcinoma
• Metastatic Urethral Carcinoma
• Papillary Renal Cell Carcinoma
• Sarcomatoid Renal Cell Carcinoma
• Stage IV Bladder Cancer AJCC v8
• Stage IV Penile Cancer AJCC v8
• Stage IV Renal Cell Cancer AJCC v8
• Stage IV Urethral Cancer AJCC v8
• Stage IVB Prostate Cancer AJCC v8
• Urachal Adenocarcinoma
• Urethral Clear Cell Adenocarcinoma

Interventions

• PROCEDURE
• DRUG
• BIOLOGICAL

No Results Yet

NCT03825835 | RECRUITING | NA

1200 participants

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-04

Start Date:

2022-06-27

Completion:

2029-09-30

Conditions

• Premature Infant
• Respiratory Distress Syndrome in Premature Infant
• Neurodevelopmental Outcome

Interventions

• DRUG

No Results Yet